Catherine Cusack - 14 Jun 2022 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Jun 2022, 12:23:44 UTC
Prior SEC filing
02 Jun 2022
Next SEC filing
02 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard K. Matros, as Attorney-in-Fact

Key filing fact

Catherine Cusack filed Form 4 for Sabra Health Care REIT, Inc. (SBRA) on 16 Jun 2022.

Key facts

  • This page summarizes Catherine Cusack's Form 4 filing for Sabra Health Care REIT, Inc. (SBRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Jun 2022, 12:23.

Change

  • Previous filing in this sequence was filed on 02 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBRA transaction

Common Stock

Award

Transaction value
$0
Shares
+8,751
Change %
+58%
Price
$0.000000
Shares after
23,959
Date
14 Jun 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 14, 2022 and ending on the earlier of June 14, 2023 or the day before the date of the next annual stockholders' meeting.

Footnote F2

Includes 8,751 unvested stock units and 10,208 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .